Oxymap - Analysing oxygenation of vitreoretinopathies and oxygen related disease in children.

Oxymap - Analysing oxygenation of vitreoretinopathies and oxygen related disease in children. - KidOxymap

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41972

Enrollment

100

Registered

2014-11-25

Start date

2015-01-14

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

retinal disease of the prematurely born infant) Coats Disease (exudative retinitis retinal vessel dilations) Amblyopia (Lazy eye) Retinopathy of prematurity (ROP

Interventions

None listed

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: - Subjects between 5 - 17 years of age - Subjects with (vitreo-) retinopathies like Retinopathy of prematurity, Coats disease, FEVR, Norries disease - Subjects with Amblyopia - Subjects with Retinititis pigmentosa

Exclusion criteria

Exclusion criteria: - Subjects with below age 5 and above 18 years of age - Subjects with ocular opacity - Subjects with Insufficient dilation of pupils after administering mydriatica - Subjects with retinal detachment. - Subjects unable to cooperate

Design outcomes

Primary

Measure	Time frame
The primary outcome will be the oxygen saturation level within the retinal vessels of the 1st en 2nd degree. The difference in the level of oxygen saturation of retinal blood vessels between the reference group of healthy eyes of the patients with amblyopia and Coats disease and several oxygen-related retinal diseases will be compared.	—

Secondary

Measure	Time frame
The diameter of the retinal blood vessels.	—

Countries

Netherlands

Outcome results